| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.28 | 0.4 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |